Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of melatonin on metabolic syndrome components in adolescent bipolar patients taking risperidone plus lithium carbonate
IRCT201208071556N44Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in cardiometabolic risk (CMR), sponsored by Tehran University of Medical Sciences. Started Sep 2012; status: completed.
02
Drugs
melatonin
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on IRCT201208071556N44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201208071556N44.